remdesivir
Commercial- Indications
- COVID-19
Company intelligence / Profile preview
Jubilant Generics has a broad portfolio of commercialized generic drugs across multiple therapeutic areas. The company supplies finished dosage formulations and active pharmaceutical ingredients globally. It leverages backward integration with in-house API production to ensure quality and cost efficiency. More than forty key products are in various stages of development for future filings.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jubilant Generics Limited.